MENU
SNES
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

SenesTech (SNES) Earnings Date & Reports

SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

SNES is expected to report earnings to rise 2.78% to -37 cents per share on March 18

SenesTech SNES Stock Earnings Reports
Q4'26
Est.
$-0.37
Q3'26
Missed
by $0.05
Q2'26
Beat
by $0.05
Q4'25
Missed
by $0.02
Q3'25
Beat
by $0.07
The last earnings report on November 10 showed earnings per share of -36 cents, missing the estimate of -31 cents. With 49.94K shares outstanding, the current market capitalization sits at 5.99M.
A.I.Advisor
Nov 10, 2026

SenesTech (SNES) Earnings Preview: Can the E-Commerce Engine Extend Its Run?

Key Takeaways

  • SenesTech is scheduled to report third-quarter 2026 results after the market close on November 16, 2026, for the period ended September 30, 2026.
  • Consensus estimates point to revenue of roughly $0.69 million and a net loss near $0.38 per share, compared with $690,000 in revenue and a $0.28 loss in the year-ago quarter.
  • The company's second quarter of 2026 set records, with revenue of $770,000, a 73.6% gross margin, and e-commerce revenue up 206% year over year.
  • Progress toward profitability remains the central theme, with cash and cash equivalents of $5.1 million at the end of the second quarter of 2026.
  • Investors will watch the in-house Amazon transition, subscription revenue growth, and expansion in agricultural and municipal channels.
  • For more information on SenesTech's Major News, Today's Price Move, Price Targets, and Forecast, explore these pages.
  • Explore Trending AI Robots to discover AI-driven trading strategies across the market.

Earnings Context and Why It Matters

SenesTech, a developer of fertility-control products for managing rodent populations, sits at a pivotal point in its growth story. The company has been shifting its e-commerce operations in-house while expanding a multi-channel strategy spanning e-commerce, retail, pest management professionals, municipalities, and agriculture. Recent quarters delivered record revenue and record gross margins, but the stock remains highly volatile and the company is still not profitable. The third-quarter 2026 report will test whether the e-commerce momentum and margin gains are durable, and whether management's push toward breakeven remains on track under new leadership following the appointment of a new CEO in mid-2026.

Earnings Expectations

Analyst consensus for the third quarter of 2026 calls for revenue of approximately $694,500, which is roughly flat compared with the $690,000 reported in the third quarter of 2025. The consensus net loss per share is about $0.38, wider than the $0.28 loss reported a year earlier, partly reflecting a larger share count from prior equity raises.

SenesTech's most recent results provide important context. In the second quarter of 2026, the company reported a record $770,000 in revenue, up 23% year over year, and a record 73.6% gross margin. E-commerce revenue surged 206% year over year to $511,000, while subscription revenue jumped 142% to $104,000. Notably, the stock still fell about 23% after-hours following that report despite the beat, underscoring how sensitive this small-cap name is to any perceived shortfall in growth or clarity on profitability.

Key metrics investors will focus on this quarter include gross margin, e-commerce and subscription revenue, operating expenses, and cash burn.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool designed to help traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps surface trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. For investors following small-cap names like SenesTech, it offers a structured way to evaluate opportunities across sectors and identify signals worth a closer look.

Market Reaction and Investor Sentiment

SenesTech is a micro-cap stock, and its shares have historically shown outsized moves around earnings. The 23% after-hours decline following the second-quarter 2026 report, despite record results, illustrates that investors are weighing the company's path to profitability as much as its top-line growth. Heading into the third-quarter release, sentiment will likely hinge on whether the e-commerce transition continues to deliver, whether subscription-based recurring revenue keeps accelerating, and whether operating expenses stay disciplined. A wider-than-expected loss, slower revenue, or any signal of additional share dilution could weigh on the stock, while sustained margin gains and revenue upside could support a more favorable reaction.

Forward Outlook and Key Factors to Monitor

Several factors will shape SenesTech's trajectory beyond this earnings event. The first is the transition of Amazon sales to in-house management. Early data from April 2026 showed e-commerce sales rising sharply year over year, and investors will want confirmation that the company can sustain that momentum without sacrificing profitability.

A second area to watch is recurring revenue. Subscription sales have been growing at a rapid clip, and a larger, more predictable revenue base would meaningfully de-risk the business model. Management has positioned direct-to-consumer and subscription channels as strategic priorities, so commentary on subscriber counts will matter.

Third, the agricultural and municipal opportunities represent potentially transformational but less predictable catalysts. A 400-acre Texas deployment reportedly showed an estimated 80% reduction in rodent activity, and expanded municipal programs in cities such as New York and Chicago continue to develop. International distribution agreements in markets like Bermuda, the U.S. Virgin Islands, and Belize add optionality.

Finally, investors should monitor the balance sheet. With roughly $5.1 million in cash at the end of the second quarter of 2026 and management indicating a runway into 2027, the rate of cash burn and any reliance on at-the-market (ATM) equity offerings will be closely watched, as dilution remains a key risk for shareholders.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biotech platform and research company

Industry ChemicalsSpecialty

Industry
Biotechnology
Address
13430 North Dysart Road
Phone
+1 928 779-4143
Employees
24
Web
https://www.senestech.com